Tech Company Financing Transactions
SpyGlass Pharma Funding Round
SpyGlass Pharma secured a $90 million Series C funding round on 7/10/2023. Backers included RA Capital Management, New Enterprise Associates and Samsara BioCapital.
Transaction Overview
Company Name
Announced On
7/10/2023
Transaction Type
Venture Equity
Amount
$90,000,000
Round
Series C
Investors
Proceeds Purpose
The company intends to use the funds to support multiple US clinical trials of its drug delivery platform.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
27081 Aliso Creek Rd 125
Aliso Viejo, CA 92656
USA
Aliso Viejo, CA 92656
USA
Phone
Website
Email Address
Overview
SpyGlass Pharma brings together our industry's brightest engineers, scientists and clinicians to develop life-changing treatment options for patients suffering from ophthalmic diseases. Together we work toward our singular focus: Long-term drug delivery--that lasts.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Patrick Mooney
Chief Operating Officer
James Dennewill
Chief Technical Officer
Glenn Sussman
President
Malik Kahook
Browse more venture capital transactions:
Prev: 7/10/2023: Gr4vy venture capital transaction
Next: 7/10/2023: Propel venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We do our best to report on every notable VC transaction. VC transactions on this site are sourced from news reports and company announcements. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs